| Nov 4 |
Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate
|
| Oct 24 |
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update
|
| Oct 19 |
FDA is said to see “path forward” for ecstasy-based drug
|
| Oct 12 |
Mind Medicine assumed with an Outperform at Leerink
|
| Sep 9 |
MindMed Announces New Employee Inducement Grants
|
| Sep 4 |
MindMed to Participate in September Investor Conferences
|
| Aug 23 |
Trials for psychedelic drug candidate for PTSD under scrutiny by FDA - report
|
| Aug 21 |
Mind Medicine: Pumping Up The Balance Sheet (Again)
|
| Aug 15 |
Lykos laying off 75% of workforce following FDA rejection of psychedelic drug for PTSD
|
| Aug 15 |
Psychedelic Stocks: Focus On Their Cash
|
